Cisplatin-mediated c-myc overexpression and cytochrome c (cyt c) release result in the up-regulation of the death receptors DR4 and DR5 and the activation of caspase 3 and caspase 9, likely responsible for the TRAIL-sensitizing effect of cisplatin

详细信息    查看全文

• 作者：Xingchao Zhu ; Kaiguang Zhang ; Qiaomin Wang ; Si Chen ; Yawen Gou…
• 关键词：Stomach neoplasms ; Cisplatin ; TNF ; related apoptosis ; inducing ligand ; Multidrug resistance ; associated proteins ; Drug resistance ; Neoplasm
• 刊名：Medical Oncology
• 出版年：2015
• 出版时间：April 2015
• 年：2015
• 卷：32
• 期：4
• 全文大小：3,384 KB
• 参考文献：1. Yang, L (2006) Incidence and mortality of gastric cancer in China. World J Gastroenterol 12: pp. 17-20
  2. Anderson, WF, Camargo, MC, Fraumeni, JJ, Correa, P, Rosenberg, PS, Rabkin, CS (2010) Age-specific trends in incidence of noncardia gastric cancer in US adults. JAMA 303: pp. 1723-1728 CrossRef
  3. Jemal, A, Bray, F, Center, MM, Ferlay, J, Ward, E, Forman, D (2011) Global cancer statistics. CA Cancer J Clin 61: pp. 69-90 CrossRef
  4. Yu, PF, Guo, JM, Xu, Q, Ying, JE, Wang, XJ, Cheng, XD, Wang, XB, Yu, CD (2010) Significance of multidrug resistance gene-associated proteins in the postoperative adjuvant chemotherapy for gastric carcinoma and the prognosis. Zhonghua Wei Chang Wai Ke Za Zhi 13: pp. 289-293
  5. Kim, DY, Kim, MJ, Kim, HB, Lee, JW, Bae, JH, Kim, DW, Kang, CD, Kim, SH (2011) Suppression of multidrug resistance by treatment with TRAIL in human ovarian and breast cancer cells with high level of c-Myc. Biochim Biophys Acta 1812: pp. 796-805 CrossRef
  6. Zhang, KG, Qin, CY, Wang, HQ, Wang, JX, Wang, QM (2012) The effect of TRAIL on the expression of multidrug resistant genes MDR1, LRP and GST-pi in drug-resistant gastric cancer cell SGC7901/VCR. Hepatogastroenterology 59: pp. 2672-2676 CrossRef
  7. Shao, SL, Cui, TT, Zhao, W, Zhang, WW, Xie, ZL, Wang, CH, Jia, HS, Liu, Q (2014) RNAi-based knockdown of multidrug resistance-associated protein 1 is sufficient to reverse multidrug resistance of human lung cells. Asian Pac J Cancer Prev 15: pp. 10597-10601 CrossRef
  8. Seo, SB, Hur, JG, Kim, MJ, Lee, JW, Kim, HB, Bae, JH, Kim, DW, Kang, CD, Kim, SH (2010) TRAIL sensitize MDR cells to MDR-related drugs by down-regulation of P-glycoprotein through inhibition of DNA-PKcs/Akt/GSK-3beta pathway and activation of caspases. Mol Cancer 9: pp. 199 CrossRef
  9. Walker, AI, Hunt, T, Jackson, RJ, Anderson, CW (1985) Double-stranded DNA induces the phosphorylation of several proteins including the 90 000?mol. wt. heat-shock protein in animal cell extracts. EMBO J 4: pp. 139-145
  10. Beurel, E, Jope, RS (2006) The paradoxical pro- and anti-apoptotic actions of GSK3 in the intrinsic and extrinsic apoptosis signaling pathways. Prog Neurobiol 79: pp. 173-189 CrossRef
  11. Lirdprapamongkol, K, Sakurai, H, Abdelhamed, S, Yokoyama, S, Athikomkulchai, S, Viriyaroj, A, Awale, S, Ruchirawat, S, Svasti, J, Saiki, I (2013) Chrysin overcomes TRAIL resistance of cancer cells through Mcl-1 downregulation by inhibiting STAT3 phosphorylation. Int J Oncol 43: pp. 329-337
  12. Wang, S (2008) The promise of cancer therapeutics targeting the TNF-related apoptosis-inducing ligand and TRAIL receptor pathway. Oncogene 27: pp. 6207-6215 CrossRef
  13. Shen, Y, White, E (2001) p53-dependent apoptosis pathways. Adv Cancer Res 82: pp. 55-84 CrossRef
  14. Cheng, EH, Wei, MC, Weiler, S, Flavell, RA, Mak, TW, Lindsten, T, Korsmeyer, SJ (2001) BCL-2, BCL-X(L) sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis. Mol Cell 8: pp. 705-711 CrossRef
  15. Wei, MC, Zong, WX, Cheng, EH, Lindsten, T, Panoutsakopoulou, V, Ross, AJ, Roth, KA, MacGregor, GR, Thompson, CB, Korsmeyer, SJ (2001) Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 292: pp. 727-730 CrossRef
  16. Zou, H, Henzel, WJ, Liu, X, Lutschg, A, Wang, X (1997) Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 90: pp. 405-413 CrossRef
  17. C
• 刊物主题：Oncology; Hematology; Pathology; Internal Medicine;
• 出版者：Springer US
• ISSN：1559-131X

文摘

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) reverses multidrug resistance (MDR) and induces apoptosis in MDR gastric carcinoma cells. In our previous study, cisplatin proved to be a sensitizing agent for TRAIL. To study the synergistic effects of cisplatin and TRAIL, we investigated the mechanism by which TRAIL reverses multidrug resistance, the role of c-myc in modulating the death receptors DR4 and DR5 and the relationship between cisplatin and cytochrome c (cyt c) release in SGC7901/VCR and SGC7901/DDP cells. We found that after treatment with TRAIL, the DNA-PKcs/Akt/GSK-3β pathway, which is positively correlated with the levels of MDR1 and MRP1, was significantly inhibited and that this tendency can be abolished by Z-DEVD-FMK (a specific caspase 3 inhibitor). We also found that suppression of c-myc by siRNA reduced the expression of DR4 and DR5 and that transfection with a pAVV-c-myc expression vector increased the expression of DR4 and DR5. Moreover, cisplatin increased the expression of c-myc in the presence of TRAIL, and there is a clear increase in cyt c release from mitochondria with the increasing concentrations of cisplatin. Meanwhile, the intrinsic death receptor pathway of caspase 9, as well as the common intrinsic and extrinsic downstream target, caspase 3, was potently activated by the release of cyt c. Together, we conclude that in TRAIL-treated MDR gastric carcinoma cells, cisplatin induces the death receptors DR4 and DR5 through the up-regulation of c-myc and strengthens the activation of caspases via promoting the release of cyt c. These effects would then be responsible for the TRAIL sensitization effect of cisplatin.